Assessing the Effects of Cancer Immunotherapy Treatment with Partek® Flow®
Cancer immunotherapy treatments that empower the immune system to fight cancer are revolutionizing cancer treatment and new single cell RNA-Seq technologies offer an unprecedented view of the tumor microenvironment. In this webinar, we will show you how to use Partek Flow to identify infiltrating immune cells in tumor biopsy samples, compare the number of each cell type in treated and untreated patients, and identify differentially regulated genes and pathways between treated and untreated patient immune cell populations.
Session One
May 29, 2018
2:00 p.m. BST (London)
Session Two
May 29, 2018
2:00 p.m. EDT (Boston)
Session Three
May 30, 2018
10:00 a.m. SGT (Singapore)
Content is identical in all sessions